BDSX Historical PE Ratio Notes

— Biodesix (NASDAQ: BDSX) is a leading data-driven diagnostic solutions company that specializes in blood-based tests for lung disease, with a strong emphasis on lung cancer detection, diagnosis, and treatment monitoring. The company uses proprietary artificial intelligence & multi-omics technologies to deliver actionable insights to physicians, aiming to improve patient outcomes through earlier and more precise disease characterization. When researching Biodesix's historical P/E ratio, it is important to recognize that as a diagnostic innovator, BDSX has faced periods of negative earnings or losses, which often result in an undefined or extremely high P/E ratio on charts and tables. This dynamic reflects market expectations for future growth & adoption of Biodesix's tests, rather than established profitability. Investors typically award higher P/E ratios to companies with disruptive technology & large addressable markets if they believe in the potential for swift revenue ramp-up, even when current earnings are weak or negative. As you review historical data, notice how BDSX's P/E ratio may fluctuate significantly in response to key events such as FDA submissions, new test launches, or changes in reimbursement policy, as these factors shape expectations for eventual profitability and sustainable earnings growth.

On this page we presented the BDSX Historical PE Ratio information for Biodesix' stock. The average BDSX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BDSX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BDSX historical PE result, against the recent PE: when this page was posted on 5/8/2026, the most recent closing price for BDSX had been 15.32, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on BDSX or any other given stock, valuation analysis for BDSX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Biodesix PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BDSX. Thanks for visiting, and the next time you need to research BDSX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.